Specialty therapeutics company focused on gastrointestinal and hepatology diseases and programs
- Year invested 2006
- Investment Stage Early
- Sectors
- Investment Status Current
- Associated Team
- Website hyperiontx.com
- Company Status IPO/Acquired (by Horizon Pharma) (Nasdaq: HPTX)